BRAVA (BRAV3) Main Indicators
Basic Data - BRAV3
| Company | BRAVA |
| Corporate Name | BRAVA ENERGIA S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Exploração. produção. refino e comercialização de petróleo. gás natural e derivados. incluindo. tratamento. processamento. estocagem. liquefação e regaseificação de gás natural. |
| Share | BRAV3 |
| Quote Date | 04/02/2025 |
| Share Type | ON |
| Last Closing | R$ 22.69 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 444.07 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Petróleo. Gás e Biocombustíveis |
| Subsector | Petróleo. Gás e Biocombustíveis |
| Segment | Exploração. Refino e Distribuição |
| Participation Indexes | IBOVESPA, IBRA, IBRX, IBRX50, IGC, IGCT, IGNM, ITAG, IVBX, SMLL |
| Updated 04/03/2025 | |
Relative Prices - BRAV3
| Price/Earnings | -11.58 |
| Price/SBV | 1.00 |
| Price/Net Sales | 1.21 |
| Price/CFO | 5.68 |
| Price/FCF | -13.32 |
| Price/Total Assets | 0.24 |
| Price/EBIT | 4.22 |
| Price/Working Capital | 2.80 |
| Price/NCAV | -0.35 |
| EV/EBIT | 10.53 |
| EV/EBITDA | 7.03 |
| EV/Net Sales | 3.01 |
| EV/CFO | 14.19 |
| EV/FCF | -33.26 |
| EV/Total Assets | 0.59 |
| Company Market Cap | R$ 10.53 B |
| Enterprise Value | R$ 26.30 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 22.69 |
| Share Price Date | 04/02/2025 |
| Dividend Yield | 1.70% |
| Updated 04/03/2025 | |
Income Statement - BRAV3
| Net Revenue | R$ 8.73 B |
| Gross Result | R$ 2.33 B |
| EBIT | R$ 2.50 B |
| Depreciation and Amortization | - R$ 1.25 B |
| EBITDA | R$ 3.74 B |
| Net Profit | - R$ 909.69 M |
| Net Profit/Share | - R$ 1.96 |
| Updated 03/20/2025 | |
| Net Revenue | R$ 1.95 B |
| Gross Result | R$ 435.73 M |
| EBIT | R$ 169.30 M |
| Depreciation and Amortization | - R$ 225.87 M |
| EBITDA | R$ 395.17 M |
| Net Profit | - R$ 1.03 B |
| Profit/Share | - R$ 2.21 |
| Updated 03/20/2025 | |
Price and Volume Behavior - BRAV3
| Lowest Price 52 weeks | R$ 15.62 |
| Highest Price 52 weeks | R$ 25.58 |
| Variation 2025 | -3.08% |
| Variation 1 year | - |
| Variation 2 years(total) | - |
| Variation 2 years(yearly) | - |
| Variation 3 years(total) | - |
| Variation 3 years(yearly) | - |
| Variation 4 years(total) | - |
| Variation 4 years(yearly) | - |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 180.41 M |
| Updated 04/03/2025 | |
Returns and Margins - BRAV3
| Return on Initial Tangible Capital | 18.46% |
| Return on Initial Invested Capital | 12.68% |
| Pre-Tax Return on Initial Tangible Capital | 27.97% |
| Pre-Tax Return on Initial Invested Capital | 19.21% |
| Return on Initial Shareholder´s Equity | -16.56% |
| Return on Initial Asset | -4.52% |
| Gross Margin | 26.68% |
| Net Margin | -10.42% |
| EBIT Margin | 28.62% |
| EBITDA Margin | 42.90% |
| Initial Asset Turnover | 0.43 |
| Financial Leverage | 4.23 |
| Liabilities/Net Worth | 3.23 |
| Net Debt/EBITDA | 4.21 |
| Updated 03/20/2025 | |
Balance Sheet - BRAV3
| Cash and Cash Equivalents | R$ 3.17 B |
| Total Assets | R$ 44.46 B |
| Short-Term Debt | R$ 941.44 M |
| Long-Term Debt | R$ 18.00 B |
| Gross Debt | R$ 18.94 B |
| Net Debt | R$ 15.77 B |
| Shareholder´s Equity | R$ 10.52 B |
| Share Book Value | R$ 22.67 |
| Common Shares | 464,179,128 |
| Preferred Shares | 0 |
| Total | 464,179,128 |
| Common Shares in Treasury | 14,166 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 14,166 |
| Common Shares (Except Treasury) | 464,164,962 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 464,164,962 |
| Updated 03/20/2025 | |
Cash Flow - BRAV3
| Operating Cash Flow | R$ 1.85 B |
| Cash Flow from Investments | R$ 975.61 M |
| Financing Cash Flow | - R$ 1.46 B |
| Increase (Reduction) in Cash and Equivalents | R$ 1.42 B |
| Updated 03/20/2025 | |
| Operating Cash Flow | R$ 653.99 M |
| Cash Flow from Investments | R$ 1.01 B |
| Financing Cash Flow | - R$ 244.89 M |
| Increase (Reduction) in Cash and Equivalents | R$ 1.39 B |
| Updated 03/20/2025 | |
Experimental - BRAV3
| CAPEX 3 months | - R$ 1.15 B |
| Free Cash Flow 3 months | - R$ 491.24 M |
| CAPEX 12 months | - R$ 2.64 B |
| Free Cash Flow 12 months | - R$ 790.77 M |
| Updated 03/20/2025 | |